Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

An association analysis of HLA-DQB1 with narcolepsy without cataplexy and idiopathic hypersomnia with/without long sleep time in a Japanese population.

Miyagawa T, Toyoda H, Kanbayashi T, Imanishi A, Sagawa Y, Kotorii N, Kotorii T, Hashizume Y, Ogi K, Hiejima H, Kamei Y, Hida A, Miyamoto M, Ikegami A, Wada Y, Takami M, Fujimura Y, Tamura Y, Omata N, Masuya Y, Kondo H, Moriya S, Furuya H, Kato M, Kojima H, Kashiwase K, Saji H, Khor SS, Yamasaki M, Ishigooka J, Wada Y, Chiba S, Yamada N, Okawa M, Kuroda K, Kume K, Hirata K, Uchimura N, Shimizu T, Inoue Y, Honda Y, Mishima K, Honda M, Tokunaga K.

Hum Genome Var. 2015 Sep 17;2:15031. doi: 10.1038/hgv.2015.31.

2.

Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 Vaccination.

Thebault S, Waters P, Snape MD, Cottrell D, Darin N, Hallböök T, Huutoniemi A, Partinen M, Pollard AJ, Vincent A.

PLoS One. 2015 Jun 19;10(6):e0129555. doi: 10.1371/journal.pone.0129555.

3.

Identification of the variations in the CPT1B and CHKB genes along with the HLA-DQB1*06:02 allele in Turkish narcolepsy patients and healthy persons.

Cingoz S, Agilkaya S, Oztura I, Eroglu S, Karadeniz D, Evlice A, Altungoz O, Yilmaz H, Baklan B.

Genet Test Mol Biomarkers. 2014 Apr;18(4):261-8. doi: 10.1089/gtmb.2013.0391.

4.

Genome-wide association studies of sleep disorders.

Raizen DM, Wu MN.

Chest. 2011 Feb;139(2):446-52. doi: 10.1378/chest.10-1313. Review.

5.

Polymorphism located between CPT1B and CHKB, and HLA-DRB1*1501-DQB1*0602 haplotype confer susceptibility to CNS hypersomnias (essential hypersomnia).

Miyagawa T, Honda M, Kawashima M, Shimada M, Tanaka S, Honda Y, Tokunaga K.

PLoS One. 2009;4(4):e5394. doi: 10.1371/journal.pone.0005394.

6.

Clinical and neurobiological aspects of narcolepsy.

Nishino S.

Sleep Med. 2007 Jun;8(4):373-99. Review.

7.

HLA haplotypes, polysomnography, and pedigrees in a case series of patients with narcolepsy.

Hayduk R, Flodman P, Spence MA, Erman MK, Mitler MM.

Sleep. 1997 Oct;20(10):850-7.

8.
9.
10.

HLA-DR2 negative narcolepsy.

Confavreux C, Gebuhrer L, Betuel H, Freidel C, Bastuji H, Aimard G, Devic M, Jouvet M.

J Neurol Neurosurg Psychiatry. 1987 May;50(5):635-6. No abstract available.

11.

Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients.

Wilkinson D, de Vries RR, Madrigal JA, Lock CB, Morgenstern JP, Trowsdale J, Altmann DM.

J Exp Med. 1988 Apr 1;167(4):1442-58.

12.

The science of clinical neurology.

Walton J.

J R Soc Med. 1986 Jan;79(1):5-14. No abstract available.

13.

Narcolepsy.

Mitler MM, Hajdukovic R, Erman M, Koziol JA.

J Clin Neurophysiol. 1990 Jan;7(1):93-118.

14.

Major histocompatibility complex class II genes and systemic sclerosis.

Briggs D, Welsh KI.

Ann Rheum Dis. 1991 Nov;50 Suppl 4:862-5. Review.

Supplemental Content

Support Center